Verition Fund Management’s Filana Therapeutics FLNA Stock Holding History

Verition Fund Management’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.8K	Buy	46,870 +8,726	+23%	+$12.4K	﹤0.01%	1968
2026 Q1	$64.5K	Buy	38,144 +10,900	+40%	+$22.4K	﹤0.01%	2089
2025 Q4	$53.9K	Sell	27,244 -4,393	-14%	-$14.1K	﹤0.01%	3375
2025 Q3	$92.1K	Hold	31,637	–	–	﹤0.01%	3607
2025 Q2	$57.3K	Sell	31,637 -103,529	-77%	-$184K	﹤0.01%	3523
2025 Q1	$203K	Sell	135,166 -11,770	-8%	-$29.7K	﹤0.01%	3045
2024 Q4	$347K	Buy	+146,936	New	+$2.58M	﹤0.01%	2691
2023 Q4	–	Sell	-25,100	Closed	-$418K	–	2638
2023 Q3	$418K	Buy	+25,100	New	+$497K	﹤0.01%	1540
2022 Q1	–	Sell	-4,867	Closed	-$213K	–	2994
2021 Q4	$213K	Buy	+4,867	New	+$255K	﹤0.01%	2217
2015 Q3	–	Sell	-2,847	Closed	-$34K	–	694
2015 Q2	$34K	Buy	+2,847	New	+$39K	0.01%	595

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Verition Fund Management's FLNA Position: Q2 2026 in Review

Verition Fund Management increased its Filana Therapeutics (FLNA) stake by 23% in Q2 2026, buying an estimated $12.4K and bringing the position to 46,870 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

Verition Fund Management first reported a position in FLNA in Q2 2015 and has held it in 10 quarters since. The position peaked at $418K in Q3 2023. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Verition Fund Management held 46,870 shares of Filana Therapeutics worth $55.8K as of Q2 2026.
Verition Fund Management bought 8,726 Filana Therapeutics shares in Q2 2026, an estimated $12.4K.
Filana Therapeutics made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1968 holding.
Verition Fund Management first reported a position in Filana Therapeutics in Q2 2015 and has held it in 10 quarters since.
Verition Fund Management's Filana Therapeutics position peaked at $418K in Q3 2023.
84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.